Tuesday, December 21, 2021 9:08:56 AM
BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has signed a stock purchase agreement with Bengbu Mali OB-GYN Hospital (the “Mali Hospital”), also known as Bengbu Mali Maternity Hospital.
The aggregate purchase price (the “Purchase Price”) for the Mali Hospital is US$16,750,000. The consideration consists of cash in the amount of US$2,800,000 and 3,000,000 newly-issued shares of common stock of BIMI (the “Parent Shares”), with an agreed upon value by the parties of US$9,000,000 at US$3.00 per share, is to be paid at the Closing.
The remainder of the purchase price of 1,650,000 shares of Common Stock valued at US$4,950,000, or $3.00 per share (the “Earnout Amount”), is subject to post-closing adjustments based on the performance of Mali Hospital in 2022 and 2023. If the net profit of Mali Hospital in 2022 equals or exceeds the net profit target, which is approximately US $770,000 (RMB 5,000,000), approximately 50% of the Earnout Amount will be paid to the sellers or their designees by the issuance of 800,000 shares of Common Stock. If the net profit target is not met, a reduced number of shares of Common Stock will be issuable based on the ratio of the actual net profit to the net profit target. The sellers or their designees will receive about 50% (or a smaller portion) of the Earnout Amount (850,000 shares of Common Stock), subject to Mali Hospital reaching a similar performance target in 2023.
“The acquisition of the Mali Hospital enhances our hospital chain for obstetrics and gynecology. We plan to shortly open new departments in this hospital, including minimally invasive plastic surgery, Ophthalmology and Rehabilitation. We predict these new departments could account for 45% of hospital’s revenue in two years,” said Mr. Tiewei Song, Chief Executive Officer and President of BIMI International Medical Inc.
About BIMI International Medical Inc.
BIMI International Medical Inc. was founded in 2006. The Company is now exclusively a healthcare products and provider, offering a broad range of healthcare products and related services and operates five private hospitals in China. For more information, please visit www.usbimi.com.
Safe Harbor Statement
Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, the Company’s ability to achieve profitable operations, its ability to continue to operate as a going concern, its ability to continue to meet NASDAQ continued listing requirements, the effects of the spread of COVID-19, the demand for the Company’s products and services in the People’s Republic of China, general economic conditions and other risk factors detailed in the Company’s annual report and other filings with the United States Securities and Exchange Commission.
IR Contact:
Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: BIMI@dgipl.com
Recent BIMI News
- BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq • GlobeNewswire Inc. • 04/23/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:03:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:01:58 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/11/2024 09:46:28 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 01/09/2024 09:19:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:33:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 01:00:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:43:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 02:11:36 PM
- BIMI Announces Results of 2023 Annual General Meeting of Stockholders • GlobeNewswire Inc. • 01/03/2024 12:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/19/2023 09:01:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 01:05:28 PM
- BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 12/19/2023 01:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/19/2023 01:00:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/18/2023 11:05:19 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:00:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 10:29:17 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/05/2023 09:48:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:01:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 01:05:27 PM
- BIMI Announces Buyback of Warrants • GlobeNewswire Inc. • 11/28/2023 01:00:00 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM